[ad_1]
According to media reports, 900,000 patients across Germany in 2017 were using drugs to treat hypertension, but it was probably contaminated with carcinogens.
The German newspaper Tagis Spiegel reported that this official information was an answer to a question asked. Opposition of the Green Party to the government in Germany
Health authorities have stated that this drug lowering blood pressure was found in a secondary substance called nitrozo di methylamine, which is classified by the World Health Organization as a substance causing cancer
. Nitrozo methylamine and other "amino-nitroses"
The effect of experiments on rodents has been observed, but it has not yet been tested on humans, according to the SPIEGEL website.
Health: In 2017, the public health insurance companies distributed about 9 million packages containing Valsartan in Germany
According to the European Medicines Agency, "there is no no acute risk to health "and significant because of this substance. The German opposition Green Party has criticized the treatment of the issue by the German authorities, saying that the agency estimates the EU is worried that these drugs will not pressure arterial exist for six years and the risk of remedying it in the long term has not yet been estimated.
Experts have asked lawmakers to oblige pharmaceutical companies to perform more rigorous tests. According to German and French news agencies, the German health authorities advised patients not to take medication for high blood pressure or to take other medicines.
The German Federal Institute of Drugs stated that patients should consult doctors and pharmacists. On the Patients should not stop taking any medication before consulting a doctor or pharmacist. 
Source link
